ConductScience.org, home

Paper410053

Pharmacological characterization of tardive dyskinesia.

Casey DE and 1 other. Psychopharmacology (Berl), 1977. Cited by 132 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Pharmacological characterization of tardive dyskinesia. Papers, record 410053. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/410053

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacological characterization of tardive dyskinesia.
PubMed
Journal
Psychopharmacology (Berl)
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
132
iCite
Relative citation ratio, by iCite
7.99
iCite
Revised in PubMed
2019-07-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Casey DED E
2Denney DD

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Dyskinesia, Drug-InducedMajor topic
Adult
Benztropine
Clinical Trials as Topic
Deanol
Dopamine
Droperidol
Humans
Levodopa
Male
Middle Aged
Parasympatholytics
Physostigmine
Placebos
Time Factors

Source PubMed

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,195,991Increase in rat brain acetylcholine induced by choline or deanol.Life Sci1975https://conductscience.org/library/papers/1195991PubMed
24,358,998Physostigmine in choreiform movement disorders.Neurology1974https://conductscience.org/library/papers/4358998PubMed
34,855,678Deanol in the treatment of levodopa-induced dyskinesias.Neurology1974https://conductscience.org/library/papers/4855678PubMed
44,418,481Effect of cholinergic and anticholinergic agents on tardive dyskinesia.J Neurol Neurosurg Psychiatry1974https://conductscience.org/library/papers/4418481PubMed
5175,391Excitation-mediating and inhibition-mediating dopamine-receptors: a new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data.Psychopharmacologia1976https://conductscience.org/library/papers/175391PubMed
61,110,712Letter: Dimethylaminoethanol for tardive dyskinesia.N Engl J Med1975https://conductscience.org/library/papers/1110712PubMed
74,865,731Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature.Am J Psychiatry1968https://conductscience.org/library/papers/4865731PubMed
85,112,211Observations on the effect of levodopa on tardive lingual-facial-buccal dyskinesia.J Neurol Sci1971https://conductscience.org/library/papers/5112211PubMed
94,692,153Parasympathetic suppression of manic symptoms by physostigmine.Arch Gen Psychiatry1973https://conductscience.org/library/papers/4692153PubMed
104,555,831Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine.Arch Gen Psychiatry1972https://conductscience.org/library/papers/4555831PubMed
113,854Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.Science1976https://conductscience.org/library/papers/3854PubMed
124,593,518Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia.Psychopharmacologia1974https://conductscience.org/library/papers/4593518PubMed
134,577,946Persistent dyskinesia.Br J Psychiatry1973https://conductscience.org/library/papers/4577946PubMed
145,676,019Pharmacological evidence for a cholinergic mechanism in brain involved in a special stereotyped behaviour of reserpinized rats.Br J Pharmacol1968https://conductscience.org/library/papers/5676019PubMed
154,214,673Comparison of thiopropazate and trifluoperazine on oral dyskinesia - a double blind study.Curr Ther Res Clin Exp1974https://conductscience.org/library/papers/4214673PubMed
164,279,1612-Dimethylaminoethanol (deanol): a brief review of its clinical efficacy and postulated mechanism of action.Curr Ther Res Clin Exp1974https://conductscience.org/library/papers/4279161PubMed
17770,514An evaluation of papaverine in tardive dyskinesia.J Clin Pharmacol1976https://conductscience.org/library/papers/770514PubMed
181,134,525Letter: Choline for tardive dyskinesia.N Engl J Med1975https://conductscience.org/library/papers/1134525PubMed
195,536,051[Effect of dioxyphenylalanine (L-DOPA) on extrapyramidal motoric hyperkineses after prolonged neuroleptic therapy].Arzneimittelforschung1970https://conductscience.org/library/papers/5536051PubMed
201,147,074Deanol in the treatment of tardive dyskinesia.Am J Psychiatry1975https://conductscience.org/library/papers/1147074PubMed

See all 42 references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 132 citations.

PMIDTitleJournalYearIn PapersSource
29,553,158Cholinergic medication for antipsychotic-induced tardive dyskinesia.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/29553158PubMed
29,409,162Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/29409162PubMed
29,341,071Anticholinergic medication for antipsychotic-induced tardive dyskinesia.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/29341071PubMed
8,867,868Risk factors for orofacial and limbtruncal tardive dyskinesia in older patients: a prospective longitudinal study.Psychopharmacology (Berl)1996https://conductscience.org/library/papers/8867868PubMed
7,373,324Oxiperomide in tardive dyskinesia.J Neurol Neurosurg Psychiatry1980https://conductscience.org/library/papers/7373324PubMed
7,047,137Management of tardive dyskinesia: current update.Drugs1982https://conductscience.org/library/papers/7047137PubMed
6,782,605Alterations in cerebrospinal fluid dopamine metabolites following physostigmine infusion.Psychopharmacology (Berl)1981https://conductscience.org/library/papers/6782605PubMed
6,775,341Dopamine, acetylcholine, and GABA effects in acute dystonia in primates.Psychopharmacology (Berl)1980https://conductscience.org/library/papers/6775341PubMed
6,135,761A comparison of purposeless movements in psychiatric patients treated with antipsychotic drugs, and normal individuals.J Neurol Neurosurg Psychiatry1983https://conductscience.org/library/papers/6135761PubMed
6,117,919Neuroleptic-induced acute dyskinesias in rhesus monkeys.Psychopharmacology (Berl)1981https://conductscience.org/library/papers/6117919PubMed
2,906,088Topographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment, and neuropsychological variables.J Neurol Neurosurg Psychiatry1988https://conductscience.org/library/papers/2906088PubMed
2,895,937GABA agonists in cebus monkeys with neuroleptic-induced persistent dyskinesias.Psychopharmacology (Berl)1988https://conductscience.org/library/papers/2895937PubMed
2,895,483Remoxipride, a selective dopamine D2 receptor antagonist, in tardive dyskinesia.Psychopharmacology (Berl)1988https://conductscience.org/library/papers/2895483PubMed
2,871,578Acute dystonia induced by neuroleptic drugs.Psychopharmacology (Berl)1986https://conductscience.org/library/papers/2871578PubMed
2,594,903Oro-facial dyskinesia and the sub-commissural part of the globus pallidus in the cat: role of acetylcholine and its interaction with GABA.Psychopharmacology (Berl)1989https://conductscience.org/library/papers/2594903PubMed
1,979,705Tardive dyskinesia.West J Med1990https://conductscience.org/library/papers/1979705PubMed
117,492Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study.Psychopharmacology (Berl)1979https://conductscience.org/library/papers/117492PubMed
112,632Dimethylaminoethanol (deanol): effect on apomorphine-induced stereotypy and an animal model of tardive dyskinesia.Psychopharmacology (Berl)1979https://conductscience.org/library/papers/112632PubMed
111,283Mood alterations during deanol therapy.Psychopharmacology (Berl)1979https://conductscience.org/library/papers/111283PubMed
111,273Dopaminergic supersensitivity: influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia.Psychopharmacology (Berl)1979https://conductscience.org/library/papers/111273PubMed

See all 22 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/410053

GET https://conductscience.org/api/papers/v1/410053/references?page=2